BRIDGEBIO PHARMA INC

Ticker: BBIO CUSIP: 10806X102 Class: EQTY

BALYASNY ASSET MANAGEMENT L.P.'s Holding History (CIK: 0001218710)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 234,389 Value ($000) $17,928 Avg Close $65.64 Range $51.85 - $78.44

Q3 2025

Shares 1,014,677 Value ($000) $52,702 Avg Close $48.77 Range $41.80 - $54.60

Q2 2025

Shares 1,641,620 Value ($000) $70,885 Avg Close $36.37 Range $28.32 - $45.48

Q1 2025

Shares 800,075 Value ($000) $27,659 Avg Close $33.72 Range $27.53 - $39.47

Q3 2024

Shares 518,806 Value ($000) $13,209 Avg Close $26.25 Range $23.40 - $32.06

Q2 2024

Shares 207,280 Value ($000) $5,250 Avg Close $27.34 Range $21.62 - $31.43

Q1 2023

Shares 220,090 Value ($000) $3,649 Avg Close $11.66 Range $7.10 - $19.95

Q1 2022

Shares 36,786 Value ($000) $373 Avg Close $10.26 Range $7.10 - $18.13

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	234,389	$17,928	$65.64	$51.85 - $78.44
Q3 2025	1,014,677	$52,702	$48.77	$41.80 - $54.60
Q2 2025	1,641,620	$70,885	$36.37	$28.32 - $45.48
Q1 2025	800,075	$27,659	$33.72	$27.53 - $39.47
Q3 2024	518,806	$13,209	$26.25	$23.40 - $32.06
Q2 2024	207,280	$5,250	$27.34	$21.62 - $31.43
Q1 2023	220,090	$3,649	$11.66	$7.10 - $19.95
Q1 2022	36,786	$373	$10.26	$7.10 - $18.13